Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives used a conference presentation to highlight the company’s shift toward ...

Tarun Kapoor is tackling a deceptively tricky biochemical challenge: how to speed up the internal machinery of living cells.

Ever since my days as a collegiate athlete, I’ve been drinking premade protein shakes. I treat them as a form of on-the-go ...

A biotech which seeks to accelerate drug discovery by providing easy access to functional proteins through its proprietary platform has extended its total Series C funding to £64.5m.

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

That quiet observation helped launch new research from Queen’s University showing that winter-active spiders make an unusually powerful antifreeze protein that lets them survive subzero temperatures ...

Nuclera’s eProtein Discovery system, which accelerates drug discovery by providing rapid, easy access to functional proteins, ...